EPIDERMAL NAEVUS SYNDROME

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting EPIDERMAL NAEVUS SYNDROME:

# Drug Count
0 PANITUMUMAB 5
1 VEMURAFENIB 4
2 GABAPENTIN 2
3 CARBOPLATIN 1
4 LEUPROLIDE ACETATE 1
See all common drugs associated with EPIDERMAL NAEVUS SYNDROME

EPIDERMAL NAEVUS SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VEMURAFENIB 4 0.0003
1 PANITUMUMAB 5 0.0003
2 LEUPROLIDE ACETATE 1 0.0000
3 CARBOPLATIN 1 0.0000
4 GABAPENTIN 2 0.0000
See all drugs enriched for association with EPIDERMAL NAEVUS SYNDROME

These drug classes are most commonly taken by patients reporting EPIDERMAL NAEVUS SYNDROME:

# Drug class Count
0 Epidermal Growth Factor Receptor Antagonist [EPC] 5
1 Kinase Inhibitor [EPC] 4
2 Platinum-based Drug [EPC] 1
See all common drug classes associated with EPIDERMAL NAEVUS SYNDROME

EPIDERMAL NAEVUS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Epidermal Growth Factor Receptor Antagonist [EPC] 5 0.0001
1 Kinase Inhibitor [EPC] 4 0.0000
2 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with EPIDERMAL NAEVUS SYNDROME